Welcome to our dedicated page for Healthy Extracts SEC filings (Ticker: HYEX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Healthy Extracts Inc. (HYEX) builds its reputation on patent-protected, plant-based nutraceuticals that target heart and brain health. Investors reviewing regulatory reports look for proof that new formulations, subscription revenue, and wholesale partnerships flow to the bottom line. For anyone who needs Healthy Extracts SEC filings explained simply, this page delivers every disclosure the moment it posts to EDGAR, ensuring nothing about intellectual-property milestones or ingredient sourcing risks is missed.
In one dashboard, Stock Titan’s AI turns a dense Healthy Extracts annual report 10-K simplified into concise summaries, flags supply-chain cost shifts in the Healthy Extracts quarterly earnings report 10-Q filing, and presents Healthy Extracts 8-K material events explained within minutes. Need to monitor leadership moves? The platform surfaces Healthy Extracts insider trading Form 4 transactions and Healthy Extracts executive stock transactions Form 4 with real-time alerts. The result is a clear Healthy Extracts earnings report filing analysis without hours of manual reading.
Analysts tracking patent expirations, marketing spend, or subscription churn can go deeper—our AI links each metric directly to the source page so understanding Healthy Extracts SEC documents with AI feels intuitive. Use search to locate royalty-agreement language, compare segment performance quarter over quarter, or download tables for modeling. Whether preparing questions for the Healthy Extracts proxy statement executive compensation discussion or watching Healthy Extracts Form 4 insider transactions real-time ahead of product launches, Stock Titan supplies the real-time data and expert context professionals need to act decisively.
Healthy Extracts Inc. (HYEX) reported Q3 2025 results and closed a transformative equity transaction. Revenue for the quarter was $917,975 versus $744,916 a year ago, but the company posted a net loss of $395,394 after higher operating expenses. For the nine months, revenue reached $2,817,910 with a net loss of $727,133.
On July 19, 2025, HYEX agreed to acquire Gummy USA LLC and issued 13,075,920 common shares, representing 77.5% of the company after the deal. Following a rescission on September 26, 2025, the merger structure was revised and the shares were re‑issued effective October 1, 2025; the $23,536,656 related amount is presented as a long‑term investment pending consolidation analysis. Shares outstanding were 16,870,868 as of September 30, 2025.
Cash was $189,452, operating cash flow used was $202,634, and derivative liabilities were $557,997. Management disclosed substantial doubt about the company’s ability to continue as a going concern within one year.
FAQ
What is the current stock price of Healthy Extracts (HYEX)?
What is the market cap of Healthy Extracts (HYEX)?
